PulmoBalance Review and Ads Breakdown

What Is PulmoBalance

PulmoBalance is presented as a respiratory-support product for people who struggle with mucus, coughing, wheezing, shortness of breath, or the feeling that their lungs are no longer as open as they used to be. The VSL does not give a standard product-label description in the provided excerpt. It does not clearly state whether the product is a capsule, powder, liquid, tincture, drink mix, or another format.

What the transcript does provide is the origin story. According to the presentation, the formula comes from research into a strange homemade soup used in a high-altitude village called Ashgooli, Georgia, described as one of the highest-altitude villages in Europe. The VSL says people in this community were exposed to harsh conditions like pollution, wood smoke, cold dry air, and viruses, yet supposedly had clearer lungs, better oxygen levels, lower inflammation, and very little long-term airway blockage.

The explanation given in the presentation is that residents drank a soup made from local mountain plants from a young age. Dr. Michael Renford, the expert figure in the story, allegedly studied those plants and concluded that they helped dissolve and clear toxic buildup from the lungs. The VSL then claims he isolated, extracted, and concentrated the most powerful compounds in order to create a more practical solution.

In other words, PulmoBalance is not introduced as a generic lung vitamin. It is framed as a concentrated version of a traditional respiratory practice, designed to target the alleged root cause behind stubborn mucus and declining breathing capacity.

The product sits in the respiratory supplement niche. Its pitch overlaps with common concerns around mucus buildup, airway comfort, inflammation, oxygen flow, lung capacity, and age-related breathing changes. But the language is more aggressive than a typical wellness pitch. The VSL repeatedly frames the issue as a hidden and dangerous process that could lead to oxygen tanks, supervised care, assisted oxygen, and loss of independence if ignored.

For a buyer, the most important distinction is this: the presentation claims PulmoBalance works by targeting pulmonary binding filaments, but the supplied transcript does not provide independent clinical validation of that mechanism. The mechanism is asserted by the VSL through authority figures and story, not proven inside the excerpt with published trial data that a reader can inspect.

The Problem It Targets

The main problem targeted by PulmoBalance is progressive breathing difficulty. The VSL describes a person whose lungs once felt open and easy but now feel restricted, heavy, and unreliable. The symptoms named in the presentation include shortness of breath, thick mucus, sticky phlegm, wheezing, coughing during conversations, gasping at night, and feeling like someone is sitting on the chest.

The emotional center of the pitch is loss of freedom. The viewer is asked to imagine avoiding stairs, planning life around breathing, waking up frightened, losing the ability to walk freely, and facing a future of inhalers, steroids, oxygen tanks, or full-time care. The VSL also says breathing problems may lead to fatigue, brain fog, poor focus, memory decline, anxiety, irritability, and reduced energy because the body is not receiving enough oxygen.

According to the presentation, many doctors allegedly dismiss these symptoms as normal aging, allergies, or mild asthma. This is an important part of the pitch. It positions the viewer as someone whose symptoms may have been underestimated by mainstream care. It also sets up the idea that ordinary treatments may only manage symptoms without addressing the alleged root cause.

The VSL lists several conventional approaches: inhalers, steroids, mucolytic drugs, antihistamines, and nebulizers. In the mother story, those options are portrayed as temporary and sometimes unpleasant. The presentation says steroids drained her energy and made her restless, inhalers caused heart palpitations, mucus thinners upset her stomach, and coughing continued anyway.

From an editorial standpoint, this is a classic direct-response move. The presentation does not merely say, “Here is a supplement for respiratory support.” It says the familiar explanations are incomplete, the common treatments are temporary, and the real enemy is something most people have never heard of.

That enemy is pulmonary binding filaments.

The VSL claims PBFs are sticky, protein-based immune structures whose job is to trap harmful particles. In a normal context, that sounds protective. But according to the presentation, modern triggers such as pollution, chemicals, water contaminants, poor air circulation, processed foods, stress, and low-grade inflammation cause the immune system to overreact and release these filaments too often.

Once chronic, the VSL says PBFs bind to mucus, make it thick and heavy, attach to airway walls, narrow the bronchi and bronchioles, trigger swelling, reduce oxygen absorption, and cause coughing, wheezing, breathlessness, fatigue, and brain fog.

That is the problem PulmoBalance is built to solve in the presentation. The product is not framed as general immune support or seasonal respiratory comfort. It is framed as a direct answer to an alleged sticky protein buildup process inside the lungs.

How PulmoBalance Works

According to the presentation, PulmoBalance works by targeting the alleged root cause of chronic breathing issues: PBF buildup. The VSL claims that these pulmonary binding filaments create protein webs that tighten around the bronchi and alveoli, thicken mucus, and make each breath harder.

The claimed solution is to neutralize, break apart, and flush out these airway-clogging proteins. The transcript uses several vivid phrases: dissolve sticky mucus, reduce airway inflammation, eliminate suffocating protein webs, restore deep breathing, open tight airways, restore oxygen flow, support lung tissue healing, and improve overall breathing.

The mechanism is presented through Dr. Michael Renford’s story. He allegedly spent 10 years studying hidden biological mechanisms inside the lungs. When Dr. Paul Whitmore contacts him about his mother’s breathing decline, Renford says the problem is not just inflammation or mucus, but overactivation of pulmonary binding filaments.

The VSL claims that most doctors treat symptoms rather than filaments. Inhalers are framed as working around the problem. Steroids are framed as temporary. Mucus thinners are described as not stopping the mucus from returning. PulmoBalance, by contrast, is positioned as working “through” the problem by addressing the protein structures that supposedly cause mucus and airway restriction in the first place.

The high-altitude soup story gives the mechanism a natural-origin explanation. According to the VSL, local mountain plants in Ashgooli contained compounds that continuously dissolved and cleared toxic buildup from the lungs. But the presentation also says a person would need to consume huge amounts of these plants every day for years to get the effect naturally. That sets up the need for a concentrated formula.

This is where PulmoBalance becomes the practical version of the soup. The VSL says the most powerful compounds were isolated, extracted, and concentrated. The claimed goals were to break apart protein filaments, clear mucus buildup, open tight airways, reduce inflammation, restore oxygen flow, support lung tissue healing, and improve breathing.

The presentation gives a dramatic example involving Renford’s father. It says that after the formula was perfected, his father’s coughing and choking disappeared completely in three weeks, and a lung scan one month later showed his lungs were already clear. This is presented as a testimonial-style story inside the VSL. It is not accompanied in the provided transcript by a published scan, medical record, dosage protocol, or independent verification.

For readers, the key takeaway is that the product’s claimed mechanism is very specific, but the transcript does not give enough evidence to confirm it. PulmoBalance is sold on the idea that sticky protein filaments are the hidden driver of mucus and airway narrowing. Whether that mechanism is clinically established would require evidence beyond this transcript.

Key Ingredients and Components

The supplied transcript does not disclose a specific PulmoBalance ingredients list. That is one of the biggest gaps in the VSL excerpt.

The presentation repeatedly describes a soup made from local mountain plants, but it does not name those plants. It says compounds were isolated, extracted, and concentrated, but it does not identify the compounds. It suggests the formula can break apart protein filaments, clear mucus, open airways, and reduce inflammation, but it does not provide a Supplement Facts panel, dosage, serving size, standardization details, allergen warnings, or safety profile.

That matters because ingredient transparency is essential in any supplement review, especially in the respiratory niche. People watching this kind of VSL may already be using medications such as inhalers, bronchodilators, steroids, antihistamines, mucolytics, antibiotics, or oxygen support. Without a disclosed formula, it is impossible to evaluate interactions, tolerability, contraindications, or whether the doses match the claims.

The transcript does give broad component clues. It describes the source as mountain plants from Ashgooli, Georgia. It says the relevant compounds were concentrated from plants used in a traditional soup. It also says the desired biological actions include mucus clearance, protein-filament breakdown, airway opening, inflammation reduction, oxygen restoration, and lung tissue support.

Because the VSL does not name ingredients, we should not pretend it does. A typical respiratory-support supplement may include botanicals, antioxidants, minerals, or nutrients commonly associated with mucus clearance, oxidative stress, immune balance, or airway comfort. But those would be typical category nutrients, not confirmed PulmoBalance ingredients.

Examples in the broader category can include herbs used for throat or airway comfort, antioxidant compounds, minerals involved in immune function, or plant extracts marketed for mucus support. Again, none of those are confirmed in the provided transcript. The only confirmed ingredient-related claim is that the formula is connected to local mountain plants and a high-altitude soup tradition.

For a careful buyer, this missing detail should be treated as a major due-diligence item. Before considering PulmoBalance, the buyer would need to see the actual label, full ingredient list, dosage amounts, inactive ingredients, manufacturing details, and warnings. The VSL’s story may create curiosity, but story is not a substitute for a transparent formula.

The VSL Hook and Story

The PulmoBalance VSL begins with a cinematic hook. It says that after years of speculation and unanswered medical questions, the truth is finally being uncovered about why many Americans can no longer breathe as they once did. It mentions beloved icons such as John Candy, Leonard Nimoy, and Aretha Franklin, saying their deaths were attributed to complications, chronic conditions, or respiratory issues, but that newly surfaced research reveals a darker hidden mechanism.

This opening does several things at once. It uses celebrity names to create familiarity and emotional weight. It creates a mystery by suggesting the public explanation is incomplete. It widens the threat by saying the mechanism is silently affecting over 170 million Americans. And it connects that threat to the viewer’s own lived experience: breathing at 20 was effortless, but breathing now feels harder every year.

The VSL then paints a before-and-after life picture. Before: stairs, long walks, laughter, singing, play, clear airways, and deep breathing. After: stopping halfway up stairs, pausing mid-sentence, waking at night coughing, wheezing, chest pressure, and mucus that feels impossible to clear.

Then comes the villain: airway-clogging proteins. The VSL says these proteins build up in the lungs, strangle air passages, thicken mucus, and make every breath harder. It describes them as microscopic protein webs that tighten around bronchi and alveoli.

The next story layer is the founder narrative. Dr. Paul Whitmore introduces himself as founder of the Whitmore Pulmonary Research Institute, says he spent eight years studying natural, non-pharmaceutical solutions for chronic breathing difficulties, published peer-reviewed papers, lectured at national conferences, and worked with over 30,000 patients.

His personal motivation is his mother. The script describes her gradual decline: getting winded across the living room, coughing in conversations, pausing mid-sentence, brushing it off as age, then worsening mucus, nighttime gasping, and wheezing. The emotional peak is a Thursday evening when she laughs, starts coughing violently, cannot inhale, turns pale, grips the couch, and whispers afterward that she thought she was going to die.

That crisis sends Whitmore searching. The VSL describes spirometry tests, blood gases, imaging scans, oxygen saturation checks, and inflammation markers. A pulmonologist allegedly warns that his mother shows early signs of chronic pulmonary decline and could need supervised care and assisted oxygen within two to three years.

From there, the story becomes an investigation. Whitmore reads studies, contacts more than 70 experts, and hears back from Dr. Michael Renford. Renford identifies pulmonary binding filaments as the overlooked mechanism. He then tells his own father story and introduces the high-altitude village where a local plant soup allegedly helped maintain lung health.

This is a layered direct-response narrative: mystery, personal pain, failed conventional options, expert rescue, exotic discovery, concentrated formula, testimonials, and implied transformation.

Ads Breakdown

The provided ad transcript uses a more blunt and visual angle than the main VSL. It opens with an oxygen mask: “I can finally say that my mom and dad do not have to wear this stupid oxygen mask anymore.” That is the ad’s core image. It makes the problem tangible in one second.

The first ad angle is oxygen mask liberation. Instead of leading with pulmonary binding filaments or mountain plants, the ad shows the burden of respiratory support. It says the speaker’s parents had to wear the mask every night and in public places like grocery stores and flights. This is designed to trigger embarrassment, fear, inconvenience, and hope.

The second angle is the mucus melting ritual. The ad says the parents found something that “completely eliminated the oxygen mask” and calls it a strange, odd-looking ritual. That phrasing creates curiosity. The viewer is meant to wonder what the ritual is and why it looks unusual.

The third angle is phlegm and mucus removal. The ad claims the once-daily ritual eliminates phlegm and mucus in the lungs and allows people to breathe normally. This is simpler than the VSL’s PBF explanation. Ads often compress the mechanism into a more visceral promise. Here, the promise is not “modulate immune-generated protein filaments.” It is “melt mucus.”

The fourth angle is broad condition targeting. The ad says it does not matter whether someone has COPD, bronchitis, asthma, or is a heavy smoker. This is an aggressive claim. From an editorial perspective, it should be treated cautiously because those are serious respiratory contexts, and the ad does not provide clinical evidence in the supplied text.

The fifth angle is family proof. The speaker says, “My mom and dad are living proof that this works.” That is not scientific proof, but it is emotionally effective. It makes the claim feel personal and immediate.

The sixth angle is a simple click call-to-action. The ad says a link is below and urges viewers to check it out. There is no detailed education, no ingredient disclosure, no pricing, and no safety discussion. The ad’s job is to make the viewer click into the longer presentation.

Compared with the main VSL, the ad is more extreme. It says the ritual “completely fixes your lungs and gets them back to 100% strength.” A careful reader should recognize that as marketing language, not verified medical language. The main review position is that such claims should not be accepted as fact without clinical evidence, especially for people with diagnosed respiratory disease.

Psychological Triggers and Persuasion Tactics

The PulmoBalance presentation uses a dense stack of persuasion tactics. The most important is the hidden cause. Instead of saying people have mucus because of ordinary irritation, the VSL introduces pulmonary binding filaments as a named mechanism. A named mechanism makes the pitch feel more scientific and proprietary.

The second tactic is fear of decline. The script repeatedly warns that symptoms may get worse, breathing capacity may deteriorate, and the viewer may end up needing oxygen tanks, inhalers, or full-time care. It also says long-term buildup may lead to irreversible damage, chronic airway obstruction, reduced lung capacity, oxygen deprivation, weakened immunity, and cardiac strain.

The third tactic is medical dismissal. The VSL says many experts dismiss symptoms as aging, allergies, or mild asthma. This positions the viewer as someone who may have been overlooked. It also makes the product’s explanation feel like a breakthrough.

The fourth tactic is authority stacking. The presentation names Dr. Paul Whitmore, Dr. Michael Renford, the Whitmore Pulmonary Research Institute, the North Shore Institute for Biomedical Sciences, the Midwest Institute of Pulmonary Biology, and several other research institutions or journals. It also mentions spirometry, blood gases, imaging, oxygen saturation, inflammation markers, peer-reviewed papers, national conferences, and 30,000 patients.

The fifth tactic is personal crisis storytelling. Whitmore’s mother is not a generic case. The VSL gives details: the living room, the couch, the Thursday evening, her panic, her pale face, the coughing attack, and the whispered fear that she thought she was going to die. These details make the story emotionally memorable.

The sixth tactic is exotic ancestral discovery. The formula is connected to a high-altitude village, mountain plants, and a soup passed down through generations. This makes the solution feel both ancient and overlooked.

The seventh tactic is before-after transformation. The VSL contrasts avoiding stairs with climbing them, gasping at night with sleeping peacefully, coughing during speech with laughing freely, and isolation with independence.

The eighth tactic is social proof. The presentation claims thousands of Americans are reversing years of breathing problems and includes testimonial-style lines about doctors being surprised, hiking again, and getting life back.

Together, these tactics create a strong emotional funnel. The viewer is moved from fear to curiosity to hope, then toward the idea that PulmoBalance may be the missing answer.

Scientific and Authority Signals

The scientific language in the PulmoBalance VSL is central to its credibility. The presentation uses terms like bronchi, bronchioles, alveoli, airway inflammation, oxygen absorption, immune-generated structures, systemic inflammation, alveolar elasticity, and cognitive performance. These terms make the pitch sound technical and medically informed.

The authority figure is Dr. Paul Whitmore. He says he founded the Whitmore Pulmonary Research Institute, dedicated eight years to natural non-pharmaceutical solutions for breathing difficulties, published multiple peer-reviewed papers, lectured nationally, and worked with over 30,000 patients. Those credentials are presented by the VSL, but the provided transcript does not include links, citations, publication names, or credential verification.

Dr. Michael Renford is the second major authority. The VSL calls him a leading immunorespiratory biologist at the North Shore Institute for Biomedical Sciences. He is used as the expert who identifies pulmonary binding filaments and explains the mountain soup discovery.

The script also references the Midwest Institute of Pulmonary Biology, the American Thoracic Research Institute, the North Carolina Center for Respiratory Immunology, the Journal of Pulmonary Cellular Sciences, and the National Institute for Environmental Lung Health. These names serve as credibility markers inside the story.

One specific study is mentioned by title: Breathing Well, The Impact of Correct Respiratory Mechanics on Cognitive Development. The VSL claims that in this study, children taught to breathe correctly saw IQ scores increase by an average of 15 points. This claim is used to connect breathing efficiency with brain oxygen and cognitive performance.

The transcript does not provide enough detail to evaluate the study design, sample size, journal, controls, publication status, or replication. So a careful review should say what the presentation claims without treating it as established fact.

The same applies to pulmonary binding filaments. The VSL explains them confidently, but the supplied transcript does not provide external citations or clinical trial data. For SEO and buyer research purposes, this is the most important scientific claim to verify before making any health decision.

What Real Buyers Say

The transcript includes several testimonial-style statements. One buyer says, “My doctor couldn't believe how much my lung function improved.” The same testimonial continues with the doctor asking what the person was taking and saying, “whatever it is, keep it up.” The customer then says, “I'm breathing easier, hiking again, and feeling more like myself every single day.”

Another testimonial says, “I used to avoid stairs completely.” The follow-up is, “Now I climb them without stopping.” The person adds that they were planning life around breathing: stairs, walks, and conversations all made them stop and catch their breath. Then comes the emotional close: “I feel like I got my life back.”

These testimonials match the VSL’s main transformation promise. They focus on everyday freedom rather than technical biomarkers. The desired outcome is not just better breathing; it is hiking, stairs, conversations, sleep, and confidence.

The ad also uses family-based proof. The speaker says their mother and father no longer need to wear an oxygen mask and that the ritual changed their lives. This is emotionally strong because it shows relief for loved ones, not only the individual user.

However, testimonials are not clinical evidence. The transcript does not provide dates, medical records, verified diagnoses, baseline lung function, follow-up testing, adverse events, or whether users changed medications. The VSL says a doctor was surprised and that lung function improved, but it does not include measurable spirometry values in the supplied excerpt.

So the most accurate reading is this: the presentation uses testimonials to support the idea that PulmoBalance may help people feel clearer, more active, and less limited by mucus and breathlessness. But those testimonials should not be treated as proof that the product treats COPD, asthma, bronchitis, or any diagnosed respiratory condition.

The Offer / Pricing / Risk Reversal

The provided transcript does not disclose the PulmoBalance price. It does not mention a bottle cost, bundle discount, subscription, shipping fee, trial, refund policy, or guarantee.

Instead, the VSL uses indirect price anchoring. It compares the problem to the burden of inhalers, steroids, mucolytic drugs, antihistamines, nebulizers, oxygen tanks, supervised care, assisted oxygen, and loss of independence. The implication is that a natural at-home solution would be preferable to an expensive or restrictive respiratory future.

This is common in supplement VSLs. The cost of the product is not introduced early. First, the presentation builds perceived value by expanding the problem: breathing difficulty affects sleep, energy, brain function, independence, family time, and future care needs. By the time pricing appears later in a full funnel, the viewer may already be comparing the product against a much larger emotional and financial burden.

The transcript also does not mention bonuses. There are no guidebooks, recipe manuals, digital protocols, coaching calls, or free-bottle incentives in the provided excerpt.

There is also no risk reversal. A strong offer normally includes a money-back guarantee, return window, or satisfaction promise. None appears in the supplied material. That does not mean no guarantee exists elsewhere in the funnel; it only means it is not present in the transcript we were given.

For buyers, this is a major missing section. Before ordering PulmoBalance, the practical questions are straightforward: What is the exact price? Is it a one-time purchase or subscription? How many servings are included? What is the refund window? Who processes returns? What are the full ingredients? Are there contraindications? Is there third-party testing? The VSL excerpt does not answer those questions.

Who This Is For (and Who It Isn't)

Based on the presentation, PulmoBalance is aimed at adults who feel their breathing has become harder with age and who are frustrated by mucus, coughing, wheezing, or reduced stamina. It is especially written for people who remember being more active and now feel limited by stairs, walking, conversation, sleep disruption, or fear of future oxygen dependence.

The ideal viewer is someone who has been told symptoms are normal aging or mild respiratory irritation but feels something deeper is happening. The VSL speaks to people who want a natural, non-pharmaceutical approach and who are open to the idea that a hidden biological mechanism may be behind their symptoms.

It also targets caregivers and family members. The ad is not spoken by the user; it is spoken by someone talking about their mother and father. That angle is designed for adult children worried about parents who use oxygen masks or struggle with breathing in public.

However, PulmoBalance is not for someone who wants a fully transparent product presentation from the first page. The transcript does not disclose the ingredient list, dosage, price, guarantee, safety warnings, or clinical trial evidence.

It is also not a substitute for medical care. Anyone with diagnosed COPD, asthma, chronic bronchitis, recurring infections, severe shortness of breath, chest pain, low oxygen saturation, oxygen use, or prescription respiratory medication should not use a supplement pitch as a replacement for professional care. The ad’s language about fixing lungs or eliminating oxygen masks is strong marketing language and should be treated cautiously.

People with allergies, medication interactions, immune conditions, pregnancy, surgery plans, or complex chronic disease would also need the actual formula and clinician guidance before considering any respiratory supplement.

Frequently Asked Questions

What is PulmoBalance?

PulmoBalance is presented as a respiratory-support formula inspired by a high-altitude homemade soup made from local mountain plants. According to the VSL, it is designed to help address mucus, airway restriction, and difficult breathing by targeting alleged pulmonary binding filaments.

What does the PulmoBalance VSL claim causes breathing problems?

The presentation claims the hidden cause is pulmonary binding filaments, or PBFs. These are described as sticky, protein-based immune structures that bind to mucus, attach to airway walls, trigger swelling, and reduce oxygen absorption.

Are PulmoBalance ingredients disclosed?

No. The provided transcript does not disclose a specific PulmoBalance ingredients list. It only says the source compounds came from mountain plants used in a traditional soup and were later isolated, extracted, and concentrated.

Does PulmoBalance replace inhalers or oxygen?

The ad says the speaker’s parents no longer needed an oxygen mask, and the VSL criticizes inhalers and steroids as symptom-management tools. But the transcript does not prove that PulmoBalance can replace prescribed respiratory care. No one should stop prescribed treatment without medical supervision.

What is the mucus melting ritual?

The ad calls the method a mucus melting ritual and says it is done once daily to clear phlegm and mucus. The main VSL connects this idea to the high-altitude soup and concentrated formula, but the provided excerpt does not reveal full instructions.

Is PulmoBalance pricing disclosed?

No. The transcript does not mention price, bundles, shipping, subscriptions, bonuses, or refunds. Any buyer would need to review the checkout page and terms before ordering.

What testimonials are used?

The VSL includes testimonials about improved lung function, easier breathing, hiking again, climbing stairs without stopping, and feeling like life was restored. These are presented as customer experiences, not verified clinical evidence.

Who should be cautious?

Anyone with serious breathing symptoms, diagnosed respiratory disease, oxygen use, or prescription respiratory medication should be cautious. The product may be marketed as natural, but the transcript does not provide enough safety information or ingredient detail to evaluate risk.

Final Take

PulmoBalance is a high-emotion respiratory supplement offer built around a strong direct-response mechanism: pulmonary binding filaments. The VSL claims these sticky protein structures clog airways, thicken mucus, reduce oxygen flow, and make breathing harder over time. The proposed solution is a concentrated natural formula inspired by a mountain-plant soup from a high-altitude village in Georgia.

As a sales story, the VSL is sophisticated. It combines celebrity references, fear of decline, a doctor-founder narrative, a mother’s crisis, mainstream medical frustration, a global expert search, an exotic discovery, and testimonials about stairs, hiking, and easier breathing. The ad funnel simplifies that into a vivid promise: a mucus melting ritual that allegedly helps people stop relying on oxygen masks.

As buyer research, the biggest concern is missing information. The transcript does not disclose the full PulmoBalance ingredients, price, guarantee, dosage, manufacturing standards, safety warnings, or clinical trial data. It makes strong respiratory claims, but the excerpt does not provide enough evidence to verify them.

The most balanced conclusion is that PulmoBalance is positioned as a natural respiratory-support supplement for people worried about mucus and declining breathing comfort. But the VSL’s claims should be treated as marketing claims from the presentation, not established medical facts. Anyone with meaningful breathing symptoms should prioritize qualified medical advice and review the full product label before considering the offer.

Disclaimer: This article is for research and educational purposes only. It is not medical, legal, or financial advice, and it is not affiliated with the product or its makers. Always consult a qualified professional before making health or financial decisions.